Study shows the efficacy of new, single-dose, oral treatment

A new, single-dose, oral treatment for sleeping sickness is as effective as current treatments and could be a key factor in eliminating disease transmission by 2030, suggests a new study published in The Lancet Infectious Diseases.

Related Keywords

Guinea , Kinshasa , Democratic Republic Of The Congo , Sherbrooke , Quebec , Canada , Congo , Antoine Tarral , Victor Kande Betu Kumeso , Jacques Pepin , Emily Henderson , University Of Sherbrooke , European Medicines Agency , Ministry Of Health , Lab Diagnostics Automation , Lab Diagnostics Automation Industry , Head Of Human African Trypanosomiasis Clinical Program , World Health Organisation , Lancet Infectious , Democratic Republic , Neglected Diseases , Human African Trypanosomiasis Clinical Program , Automation Industry Focus , Neglected Tropical Diseases Expert Advisor , European Medicines , Professor Jacques Pepin , Infectious Diseases , Adolescents , Neglected Tropical Disease , Ropical Disease ,